Collagen Wound Dressing Market: Global Size, Share, Trends, Growth and Forecast, 2022-2032

Collagen wound dressing is an emerging technique involved in the healing of various necrotic or partial-thickness injuries along with second-degree burns and skin grafts. The dressings are available in the form of gels, pads, particles, pastes, powders, freeze-dried sheets or solutions.

As collagen is one of the body's key natural resources and a component of skin tissue, it has a large number of medical uses in treating complications of the bones and skin. It has natural wound healing properties which artificial wound dressings do not have and is thus used as an ideal biomaterial for wound-healing dressings. It amplifies wound healing and granulation tissue formation, supports neovascularization, and reduces bacterial infection in chronic wounds.

Collagen dressings are available in various pore sizes, which make it mandatory to use a secondary dressing. They are biodegradable and nontoxic in nature and provide additional benefits such as ease of comfort and mobility to the patients.

The global collagen dressings market is projected to expand at a CAGR of around 9.7% during the 2022 to 2032 period.


The growth of this market is attributed towards major relying factors including: the growing number of road accidents and traumatic injuries across the globe, the increasing prevalence of chronic, surgical and acute wounds, the growing adoption of collagen in advanced wound dressings, the high rate of cesarean sections in elderly women, the increasing demand for effective wound care products and treatments, and the high adoption of wound healing and matrix of biological tissues along with treatment for wounds etc.

Additionally, a handful number of major start-of-the-art technologies and investments in R&D activities within the wound care management space in the healthcare sector have been recently witnessed. Various innovations, testing of new wound care management techniques & procedures, and increasing use of animal-based dressing materials have effectively led to the advent of new products for skin treatments and collagen dressing. Replacements in traditional dressing techniques and new alternatives are increasing the demand for multifunctional collagen dressings due to the desirable and optimal functional properties and benefits that they offer.

Moreover, the latest generations of collagen dressing alternatives are seen to put forward greater enzymatic stability at the macroscopic level, aid in regulating the chronic wound microenvironment at the biochemical level, and propose room for customization for enabling treatment of a broad range of chronic wounds. This is resulting in the creation of wide range of opportunities for the participants involved in the current collagen dressing’s market and is leading towards the expansion of the global market stupendously.

Furthermore, other factors such as the increasing cases of obesity around the globe, the increasing binge eating and consumption of junk foods across regions and the growing disregard towards regular exercise leading to rising levels of stress further boost the growth of collagen wound dressing market.

However, factors such as high production costs and complexities involved while collecting and storing collaged dressings contribute to the hindrance of growth of this market.


By Dressing Type:

  • Antimicrobial Collagen Dressings
  • Alginate Collagen Dressings
  • Hydrogel Collagen Dressings
  • Native Collagen Dressings
  • Others

By Source:

  • Synthetic
    • Polymers
    • Ethylene Diamine Tetraacetic Acid (EDTA)
    • Oxidized Regenerated Cellulose (ORC)
  • Natural
    • Avian
    • Porcine
    • Bovine
    • Others

By Form:

  • Gels
  • Powders
  • Pastes
  • Others

By Application:

  • Acute Wounds
  • Chronic Wounds

By Distribution Channel:

  • Hospitals
  • Clinics
  • Retail Pharmacy
  • Ambulatory Surgical Centers
  • Online Stores
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


The North American region holds the largest share in the collagen wound dressing market and is to continue to remain at the top in the coming years as well. This is owing to factors such the increasing number of traumatic injuries & chronic wounds in the region, the surging awareness among healthcare providers about advanced wound care management products, the growing healthcare expenditure in the region and the presence of various key market players in the region etc. The major contributor to the region is the U.S.

The Asia Pacific region is the fastest growing regional market for collagen wound dressing. It is anticipated that this region will continue to grow substantially in the forthcoming years as well which can be attributed to factors such as the expansion of the healthcare sector in major economies of the region, the increasing number of technological advancements and proliferation in adoption of advanced wound care products and treatments for chronic wound treatment etc. The major contributors to the region include India, Japan and China.


  • Lohmann & Rauscher International Gmbh & Co.
  • Dermarite Industries Llc
  • Urgo Medical
  • Shield Line
  • Zeni Medical
  • Winner Medical Co. Ltd.
  • Coloplast Corporation
  • Organogenesis Inc.
  • Smith & Nephew Plc
  • Acelity L.P. Inc.
  • Collagen Matrix Inc.
  • Medtronic Plc Hollister Incorporated
  • B. Braun Melsungen Ag
  • Bsn Medical
  • Angelini S.P.A.
  • Covalon Technologies Ltd.
  • Human Biosciences
  • 3M
  • Deroyal Industries Inc.
  • Paul Hartmann Ag
  • Advancis Medical
  • Cardinal Health
  • Integra Lifesciences Holdings Corporation
  • Mölnlycke Health Care Ab
  • Convatec Group Plc
  • Medline Industries Inc.
  • Advanced Medical Solutions Group Plc
  • Collplant Ltd.
  • Ethicon Inc.
  • Other Players


  • In December 2020, Collagen Matrix, Inc., a global leader in regenerative, collagen-based, xenograft-derived medical devices, and Portfolio Company of Linden Capital Partners announced the acquisition of Sunstar's Degradable Solutions division including its GUIDOR® branded line of resorbable synthetic medical implants.
  • In February 2021, Fibralign Corp., a Stanford spin-out and developer of therapeutic biomedical devices, announced enrollment of the first patient in a multi-site, randomized clinical trial in Europe evaluating its BioBridge Collagen Matrix as a novel preventative treatment for secondary lymphedema.

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

Get a Customized Version
Get 10% discount on any market research report of your choice.
  • Publication date: 20th September 2023
  • Base year: 2022
  • Forecast year: 2023-2033
  • Format: PDF, PPT,Word,Excel

- ISO Certified Logo -

-: Our Clients :-

Subscribe to Our Company Updates

* We will not share your personal information with anyone
Go Up